Search
for
Sort by
Research 151–180 of 1000+
- Manganese-Doped Calcium Silicate Nanowire Composite Hydrogels for Melanoma Treatment and Wound Healing
- Cutaneous adverse effects of BRAF inhibitors in metastatic malignant melanoma, a prospective study in 20 patients.
- Activation of TRPV4 Induces Exocytosis and Ferroptosis in Human Melanoma Cells
- Blood MUC-18/MCAM expression in patients with melanoma: a suitable marker of poor outcome
- Bioabsorbable nano-micelle hybridized hydrogel scaffold prevents postoperative melanoma recurrence
- Nature-skin-based multi-responsive controlled-release electroactive scaffolds for integrated melanoma postoperative relapse prevention and wound therapy
- A case of bullous pemphigoid in a malignant melanoma patient following an increased Th2/Th1 ratio in peripheral blood cells after nivolumab treatment
- Anticancer potential of musa × paradisiaca as cervical carcinoma and malignant melanoma
- Recent Advances in Genetically Engineered Mouse Models of Melanoma: Insights into Tumor Initiation and Oncogenic Signaling Pathways
- Bioorthogonal Catalytic Microneedles Based on a Cytotoxic PEI Matrix for Synergistic Melanoma Therapy
- A bibliometric study of the top 100 most cited articles on melanoma: insights into research trends and characteristics
- Differential effects of dehydroepiandrosterone (DHEA) between mouse and human melanoma cell lines
- The Cutaneous Side Effects of Selective BRAF Inhibitors and Anti-CTLA4 Agents: the Growing Role of the Dermatologist in the Management of Patients with Metastatic Melanoma
- Cutaneous manifestations of dabrafenib (GSK2118436): a selective inhibitor of mutant BRAF in patients with metastatic melanoma
- A Prospective Study of Cutaneous Adverse Events Induced by Low-Dose Alpha-Interferon Treatment for Malignant Melanoma
- Hair and nail adverse events during treatment with targeted therapies for metastatic melanoma
- Effect of adipose-derived stem cell-conditioned medium on the proliferation and migration of B16 melanoma cells
- The risk of dermatological toxicities of combined BRAF and MEK inhibition versus BRAF inhibition alone in melanoma patients: a systematic review and meta-analysis
- 42197 The Impact of the COVID-19 Pandemic on Sun Habits of Patients with Melanoma: A Cross- sectional Study
- Morphologic comparison of cultured human epidermis melanocytes,amelanotic melanocytes from hair follicles and mouse melanoma cells observed by atomic force microscope
- Expression patterns of MITF during human cutaneous embryogenesis: evidence for bulge epithelial expression and persistence of dermal melanoblasts
- Logic-based modeling and drug repurposing for the prediction of novel therapeutic targets and combination regimens against E2F1-driven melanoma progression
- Characteristics and survival outcomes of untreated, resectable stage I–III melanoma patients in Serbia
- A pilot study examining the educational impact of an evidence-based lymphedema booklet for newly diagnosed melanoma patients
- Fibroblast heterogeneity and functions: insights from single-cell sequencing in wound healing, breast cancer, ovarian cancer and melanoma
- Multicentric parallel phase II trial of the polo-like kinase 1 inhibitor BI 2536 in patients with advanced head and neck cancer, breast cancer, ovarian cancer, soft tissue sarcoma and melanoma. The first protocol of the European Organization for Research and Treatment of Cancer (EORTC) Network Of Core Institutes (NOCI)
- <i>In-Vitro</i> Effect of Sex Steroids on Mouse Melanoma (B16F10) Cell Growth
- Skin melanocytes: biology and development
- The cutaneous serotoninergic/melatoninergic system: securing a place under the sun
- Serotoninergic and melatoninergic systems are fully expressed in human skin